Taufon

General characteristics. Structure:

Active agent: taurine – 40 mg;

Excipients: methylparahydroxybenzoate - 1 mg, the water purified – to 1 ml.

Pharmacological properties:

Тауфон® (taurine) is the sulfur-containing amino acid which is formed in an organism in the course of cysteine transformation. Drug promotes improvement of power processes, stimulates reparative processes at the diseases of dystrophic character and processes which are followed by considerable disturbance of metabolism of tissues of eye. As sulfur-containing amino acid drug contributes to normalization of function of cellular membranes, improvement of power and exchange processes.

Indications to use:

Drug is appointed the adult at cornea dystrophies, senile, traumatic, beam and other types of cataracts, and also at cornea injuries (as a stimulator of reparative processes).

Route of administration and doses:

At cataracts of 4% solution of a taufon (eye drops) is appointed in the form of instillations on 1-2 drops by 2-4 times a day within 3 months. The course is repeated with a monthly interval. At injuries and dystrophic diseases of a cornea apply in the same doses within one month.

Features of use:

There are no data.

Side effects:

Allergic reactions.

Interaction with other medicines:

There are no data.

Contraindications:

Hypersensitivity to taurine.

Overdose:

There are no data.

Storage conditions:

In the place protected from light at a temperature not above 25 °C.
To store in the place, unavailable to children.

Issue conditions:

Without recipe

Packaging:

On 10 ml in the sterile polymeric bottles droppers which are hermetically closed by the polymeric traffic jams droppers and covers screwed.
On 1 polymeric bottle dropper together with the instruction on a medical use place in a pack from a cardboard.